Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group
  2. Taxonomy
  3. Term
  4. Other

Improved graft survival after renal transplantation in the United States, 1988 to 1996

Go back to Resources

Improved graft survival after renal transplantation in the United States, 1988 to 1996

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Improved graft survival after renal transplantation: an analysis of United Network for Organ Sharing (UNOS) Data

Go back to Resources

Improved graft survival after renal transplantation: an analysis of United Network for Organ Sharing (UNOS) Data

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Interim monitoring in the supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP) study: Design and implementation

Go back to Resources

Interim monitoring in the supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP) study: Design and implementation

Authors:

Location:

Go back to Resources

NCI expanded participation project

Go back to Resources

NCI expanded participation project

Authors:

Location:

Go back to Resources

NIAID AIDS Vaccine Evaluation Group. Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp 120 prime-boost HIV-1 vaccine

Go back to Resources

NIAID AIDS Vaccine Evaluation Group. Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp 120 prime-boost HIV-1 vaccine

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Should the definition of preeclampsia include a rise in diastolic blood pressure of >/=15 mm Hg to a level < 90 mm Hg in association with proteinuria?

Go back to Resources

Should the definition of preeclampsia include a rise in diastolic blood pressure of >/=15 mm Hg to a level < 90 mm Hg in association with proteinuria?

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

Go back to Resources

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Cyclosporine to tacrolimus: rejection, toxicity and cardiovascular risks

Go back to Resources

Cyclosporine to tacrolimus: rejection, toxicity and cardiovascular risks

Authors:

Location:

Go back to Resources

Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group

Go back to Resources

Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Diminution of the Anti-PRP response to a combined DtaP/Hib vaccine by concurrent inactivated poliovirus vaccination

Go back to Resources

Diminution of the Anti-PRP response to a combined DtaP/Hib vaccine by concurrent inactivated poliovirus vaccination

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • Previous page ‹‹
  • Page 124
  • Next page ››
Subscribe to Other
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification